Rocket Lab's Neutron Slip Tests Investor Patience Even as Backlog Hits a Record
Published on 08/11/2026 at 20:10 | Redaktion boerse-global.de
There is a peculiar rhythm to Rocket Lab's stock these days: one step forward on the order book, one step back on the launch pad. The company posted its best quarterly revenue ever on Monday, then promptly told investors the debut of its much-anticipated Neutron rocket would slide into 2027. Shares fell more than 9 percent in pre-market US trading on Tuesday, a stark reminder that in aerospace, the calendar is the one thing money can't buy.
A Quarter of Records, With a Catch
The numbers themselves were hard to fault. Second-quarter revenue came in at $234.07 million, up 62 percent year over year and ahead of the $230.94 million analysts had penciled in. The order book swelled to a record $2.36 billion as of June 30, a 137 percent jump from a year earlier, fueled by more than $1 billion in fresh contract wins.
The bottom line, however, told a slightly different story. Rocket Lab posted a net loss of $49.3 million, an improvement from the $66.4 million loss in the year-ago quarter, but the per-share loss of 8 cents came in a touch wider than the 7.67-cent consensus. Transaction costs of $8.6 million tied to the Mynaric and Motiv acquisitions, along with the planned Iridium deal, weighed on the quarter.
The guidance for the current period is where the market's attention zeroed in. Management sees third-quarter revenue of $250 million to $265 million, with the midpoint comfortably above the $235.9 million analysts had been modeling. But the GAAP gross margin forecast of 29 to 31 percent landed well short of the 37.6 percent consensus, and the adjusted EBITDA loss is expected to run between $17 million and $23 million.
CFO Adam Spice attributed the margin pressure to a shifting revenue mix: satellite platforms carry thinner margins than launch services, and they now dominate the business. Space Systems contributed $189.5 million in the quarter, roughly 81 percent of total revenue, while Launch Services trailed at $44.6 million. The company is no longer primarily a rocket company in the traditional sense — it's a satellite manufacturer that happens to fly its own hardware.
Should investors sell immediately? Or is it worth buying Rocket Lab?
Neutron's Slip and the Ripple Effect
The Neutron delay is the kind of news that cuts both ways. On one hand, the rocket is central to Rocket Lab's ambition of competing in the heavy-lift segment. On the other, the company has never promised a flawless timeline, and CEO Peter Beck has consistently emphasized reusability over speed.
The revised plan targets delivering the vehicle to the pad in the fourth quarter of 2026, with a first flight now expected sometime in 2027. An integrated static fire test in Virginia remains the biggest outstanding risk. Beck noted the focus is on getting the vehicle right rather than racing to the launch date, while Spice expressed cautious optimism about staying within the broader schedule.
The stakes extend well beyond pride. A dedicated Neutron mission for Canadian network operator Kepler Communications — the first time Kepler has booked an entire rocket rather than a rideshare slot — is slated for no earlier than 2028. More consequentially, the $397 million US Space Force contract for the SB-AMTI satellite constellation depends on Neutron's success. Every month the rocket slips is a month the monetization of those contracts moves further out.
Wall Street Shrugs Off the Delay
What's striking is how little the analyst community seems rattled. Cantor Fitzgerald raised its price target from $96 to $122 on Tuesday, maintaining an "Overweight" rating and pointing to the record quarter. KeyBanc reaffirmed its "Overweight" stance with a $135 target, citing accelerating momentum in Space Systems even as Neutron costs climb. Other firms cluster in the $130 to $132 range, all with positive ratings.
The message from the Street: a schedule shift of a few quarters doesn't alter the structural growth trajectory. Whether that patience holds if Neutron slips again is another question entirely.
Defense Dollars and a European Beachhead
The real engine of Rocket Lab's expansion is the US military's appetite for flexible, rapidly deployable space infrastructure. Beyond the SB-AMTI award, the company landed a $266 million Space Force contract in late July for up to 18 suborbital missions supporting missile defense testing. The portable GHOST launch system, designed to fit in shipping containers for deployment anywhere in the world, positions Rocket Lab as a provider of quickly relocatable launch capacity.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
The company is also planting flags in Europe. On Monday, it established Rocket Lab Germany GmbH, building on the Mynaric acquisition to expand satellite manufacturing and launch services on the continent. Beck argues Europe faces gaps in both launch vehicles and spacecraft production and will need thousands of satellites over the next decade to secure technological sovereignty.
The $8 billion Iridium acquisition, expected to close around mid-2027, ties the strategy together: vertical integration, defense contracts, and constellation operations under one roof.
The Market's Verdict
Investor sentiment has been whipsawing. The stock closed Monday at €69.60, down 3.06 percent, and continued sliding Tuesday to €67.50, off another 3.02 percent in German trading. Over the past week, however, the shares are still up 4.65 percent, and the 12-month gain stands at a formidable 78.46 percent. The stock sits just 0.49 percent below its 200-day moving average — essentially at its long-term mean.
The question for shareholders is no longer whether Rocket Lab is growing; the backlog and revenue figures answer that emphatically. The real test is how much schedule slippage the market will tolerate before the growth story starts to read as a patience play. With Neutron's first flight now a year and a half away at best, and the Iridium deal still pending regulatory approval, the coming quarters will reveal whether investors' faith is built on the order book — or on promises yet to lift off.
Ad
Rocket Lab Stock: New Analysis - 11 August
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
